DBIA
CRL icon

Dumont & Blake Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,125
Closed -$823K – 207
2025
Q4 		$823K Sell
4,125
-115
-3% -$20.9K 0.2% 112
2025
Q3 		$663K Sell
4,240
-60
-1% -$9.53K 0.16% 127
2025
Q2 		$652K Buy
4,300
+20
+0.5% +$2.67K 0.17% 127
2025
Q1 		$644K Buy
4,280
+5
+0.1% +$838 0.18% 121
2024
Q4 		$789K Sell
4,275
-85
-2% -$16.4K 0.21% 107
2024
Q3 		$859K Sell
4,360
-4,360
-50% -$906K 0.23% 107
2024
Q2 		$1.8M Buy
8,720
+4,305
+98% +$975K 0.26% 96
2024
Q1 		$1.2M Buy
4,415
+62
+1% +$14.8K 0.34% 81
2023
Q4 		$1.03M Sell
4,353
-135
-3% -$26.5K 0.32% 87
2023
Q3 		$880K Buy
4,488
+25
+0.6% +$5.13K 0.3% 86
2023
Q2 		$938K Buy
4,463
+15
+0.3% +$2.98K 0.3% 85
2023
Q1 		$898K Buy
4,448
+2,085
+88% +$473K 0.3% 88
2022
Q4 		$515K Sell
2,363
-5
-0.2% -$1.09K 0.18% 123
2022
Q3 		$466K Buy
+2,368
New +$511K 0.17% 130

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dumont & Blake Investment Advisors's CRL Position: Q1 2026 in Review

Dumont & Blake Investment Advisors sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 4,125 shares — an estimated $823K sold.

Dumont & Blake Investment Advisors first reported a position in CRL in Q3 2022 and held it in 14 quarters. The position peaked at $1.8M in Q2 2024. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Dumont & Blake Investment Advisors reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Dumont & Blake Investment Advisors sold 4,125 Charles River Laboratories shares in Q1 2026, an estimated $823K.
  • Dumont & Blake Investment Advisors first reported a position in Charles River Laboratories in Q3 2022 and held it in 14 quarters.
  • Dumont & Blake Investment Advisors's Charles River Laboratories position peaked at $1.8M in Q2 2024.
  • 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.